MiMedx Group, Inc. (MDXG) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 38.50M USD | Liabilities, Current |
| Cash and equivalents | 135.84M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 41.30M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 20.93M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $38.50M | $135.84M | (m) | $41.30M | $20.93M | (m) |
| 2026-03-31 | (m) | $44.55M | $159.77M | (m) | $46.03M | $26.23M | (m) |
| 2025-12-31 | (m) | $64.27M | $166.12M | (m) | $75.71M | $25.34M | (m) |
| 2025-09-30 | (m) | $57.68M | $142.08M | (m) | $78.19M | $26.50M | (m) |
| 2025-06-30 | (m) | $50.29M | $118.87M | (m) | $69.23M | $24.89M | (m) |
| 2025-03-31 | (m) | $42.62M | $106.43M | (m) | $62.29M | $24.07M | (m) |
| 2024-12-31 | (m) | $45.59M | $104.42M | (m) | $55.83M | $23.81M | (m) |
| 2024-09-30 | (m) | $41.94M | $88.80M | (m) | $54.03M | $24.25M | (m) |
| 2024-06-30 | (m) | $40.01M | $69.04M | (m) | $52.80M | $25.06M | (m) |
| 2024-03-31 | (m) | $42.22M | $48.49M | (m) | $57.02M | $24.45M | (m) |
| 2023-12-31 | (m) | $46.01M | $82.00M | (m) | $53.87M | $21.02M | (m) |
| 2023-09-30 | (m) | $43.63M | (m) | (m) | $49.01M | $19.07M | (m) |
| 2023-06-30 | (m) | $44.46M | $68.65M | (m) | $48.96M | $16.82M | (m) |
| 2023-03-31 | (m) | $40.87M | $61.22M | (m) | $44.69M | $14.66M | (m) |
| 2022-12-31 | (m) | $43.56M | $65.95M | (m) | $43.08M | $13.18M | (m) |
| 2022-09-30 | (m) | $45.86M | $73.22M | (m) | $40.83M | $13.98M | (m) |
| 2022-06-30 | (m) | $37.14M | $72.50M | (m) | $37.66M | $13.38M | (m) |
| 2022-03-31 | (m) | $36.59M | $75.68M | (m) | $37.67M | $13.17M | (m) |
| 2021-12-31 | (m) | $42.36M | $87.08M | (m) | $40.35M | $11.39M | (m) |
| 2021-09-30 | (m) | $41.75M | $90.61M | (m) | $36.54M | $11.20M | (m) |
| 2021-06-30 | (m) | $50.57M | $85.01M | (m) | $37.24M | $10.14M | (m) |
| 2021-03-31 | (m) | $55.41M | $84.75M | (m) | $35.42M | $11.58M | (m) |
| 2020-12-31 | (m) | $59.16M | $95.81M | (m) | $35.42M | $10.36M | (m) |
| 2020-09-30 | (m) | $57.30M | $109.59M | (m) | $33.04M | $11.02M | (m) |
| 2020-06-30 | (m) | $63.66M | $48.19M | (m) | $30.10M | $10.56M | (m) |
| 2020-03-31 | (m) | $63.70M | $53.52M | (m) | $31.93M | $9.25M | (m) |
| 2019-12-31 | (m) | $67.32M | $69.07M | (m) | $32.33M | $9.10M | (m) |
| 2019-09-30 | (m) | $73.37M | $94.12M | (m) | $21.39M | $12.03M | (m) |
| 2019-06-30 | (m) | $78.10M | $96.93M | (m) | (m) | $14.95M | (m) |
| 2019-03-31 | (m) | $64.35M | $28.38M | (m) | (m) | $16.43M | (m) |
| 2018-12-31 | (m) | $71.55M | $45.12M | (m) | (m) | $15.99M | (m) |
| 2017-12-31 | (m) | $45.81M | $27.48M | (m) | (m) | $9.47M | (m) |
| 2017-09-30 | (m) | $35.16M | $36.52M | (m) | $59.58M | $10.42M | (m) |
| 2017-06-30 | (m) | $51.51M | $47.53M | (m) | $60.74M | $15.03M | (m) |
| 2017-03-31 | (m) | $49.60M | $30.92M | (m) | $66.85M | $16.05M | (m) |
| 2016-12-31 | (m) | $50.73M | $34.39M | (m) | $67.15M | $17.81M | (m) |
| 2016-09-30 | (m) | $41.58M | $18.34M | (m) | $63.43M | $18.31M | (m) |
| 2016-06-30 | (m) | $38.54M | $23.80M | (m) | $54.86M | $17.21M | (m) |
| 2016-03-31 | (m) | $28.84M | $15.12M | (m) | $53.88M | $17.97M | (m) |
| 2015-12-31 | (m) | $26.78M | $28.49M | (m) | $53.76M | $7.46M | (m) |
| 2015-09-30 | (m) | $24.35M | $41.07M | (m) | $46.78M | $5.65M | (m) |
| 2015-06-30 | (m) | $19.46M | $38.60M | (m) | $39.45M | $3.86M | (m) |
| 2015-03-31 | (m) | $18.46M | $38.70M | (m) | $31.00M | $4.25M | (m) |
| 2014-12-31 | (m) | $18.40M | $46.58M | (m) | $26.67M | $5.13M | (m) |
| 2014-09-30 | (m) | $14.45M | $47.25M | (m) | $23.30M | $4.74M | (m) |
| 2014-06-30 | (m) | $9.91M | $39.25M | (m) | $20.50M | $4.23M | (m) |
| 2014-03-31 | (m) | $9.59M | $43.02M | (m) | $18.97M | $3.64M | (m) |
| 2013-12-31 | (m) | $9.61M | $44.08M | (m) | $16.09M | $3.88M | (m) |
| 2013-09-30 | (m) | $8.33M | $6.06M | (m) | $13.71M | $4.53M | (m) |
| 2013-06-30 | (m) | $6.14M | $4.19M | (m) | $11.76M | $4.22M | (m) |
| 2013-03-31 | (m) | $5.97M | $5.73M | (m) | $9.82M | $3.96M | (m) |
| 2012-12-31 | (m) | $5.07M | $6.75M | (m) | $7.65M | $3.02M | (m) |
| 2012-09-30 | (m) | $10.55M | $7.62M | (m) | $6.17M | $1.80M | (m) |
| 2012-06-30 | (m) | $8.24M | $2.65M | (m) | $3.95M | $961.94K | (m) |
| 2012-03-31 | (m) | $6.80M | $3.02M | (m) | $2.85M | $795.52K | (m) |
| 2011-12-31 | (m) | $7.92M | $4.11M | (m) | $1.89M | $712.60K | (m) |
| 2011-09-30 | (m) | $6.83M | $637.19K | (m) | $1.50M | $609.14K | (m) |
| 2011-06-30 | (m) | $5.56M | $1.61M | (m) | $1.21M | $561.92K | (m) |
| 2011-03-31 | (m) | (m) | $1.02M | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $1.25M | $1.34M | (m) | $162.38K | $111.55K | (m) |
| 2010-09-30 | (m) | (m) | $428.49K | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | $2.73M | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | (m) | $2.65M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |